Log in to save to my catalogue

Clevidipine and COVID 19: From Hypertension to Inflammatory Response

Clevidipine and COVID 19: From Hypertension to Inflammatory Response

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b4c28e251a4049aa95d2f1cafcc0b1f2

Clevidipine and COVID 19: From Hypertension to Inflammatory Response

About this item

Full title

Clevidipine and COVID 19: From Hypertension to Inflammatory Response

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Journal of inflammation research, 2022-01, Vol.15, p.2383-2386

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Globally, more than 4 million have died from COVID-19, World Health Organization (WHO) to declare COVID-19 a pandemic. The COVID 19 pathology, produced by SARS-COV2, a virus from the coronavirus family, emerged at the end of 2019. The majority of cases usually have a mild or moderate form, characterized by fever, cough, intense asthenia and multipl...

Alternative Titles

Full title

Clevidipine and COVID 19: From Hypertension to Inflammatory Response

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b4c28e251a4049aa95d2f1cafcc0b1f2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b4c28e251a4049aa95d2f1cafcc0b1f2

Other Identifiers

ISSN

1178-7031

E-ISSN

1178-7031

DOI

10.2147/JIR.S350822

How to access this item